Condition (MeSH)
Toxoplasmosis, Ocular
ClinicalTrials.gov lists 3 trials for Toxoplasmosis, Ocular or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
3 of the 3 trials are tagged with Toxoplasmosis, Ocular itself; the rest are tagged with a narrower condition beneath it.
When did Toxoplasmosis, Ocular trials start? (3)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 3
- Observational
Top of scale: 1
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2011 | 1 |
| 2010 | 1 |
| 2002 | 1 |
No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 3 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Toxoplasmosis, Ocular trials in? (2)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 3 | 1 |
| Observational | 2 |
How many Toxoplasmosis, Ocular trials are recruiting? (1)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Completed | 3 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which publications cover Toxoplasmosis, Ocular? (13)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Non-cytomegalovirus ocular opportunistic infections in patients with acquired immunodeficiency syndrome. | American journal of ophthalmology | 2013 | Yes |
| Respective roles of acquired and congenital infections in presumed ocular toxoplasmosis. | American journal of ophthalmology | 2008 | Yes |
| Ocular manifestations in congenital toxoplasmosis. | Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie | 2006 | Yes |
| Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis. | Ophthalmology | 2005 | Yes |
| Toxoplasmosis. | Seminars in ophthalmology | 2005 | Yes |
Showing 5 of 13 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.